BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 31491605)

  • 1. Mono-2-ethylhexyl phthalate (MEHP) promoted lipid accumulation via JAK2/STAT5 and aggravated oxidative stress in BRL-3A cells.
    Zhang Y; Wang S; Zhao T; Yang L; Guo S; Shi Y; Zhang X; Zhou L; Ye L
    Ecotoxicol Environ Saf; 2019 Nov; 184():109611. PubMed ID: 31491605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of formyl peptide receptor 2 in steatosis of L02 cells exposed to Mono-(2-ethylhexyl) phthalate.
    Feng X; Zhang R; Miao X; Li X; Cui J; Xu H; Fang X; Zhou C; Ye L; Zhou L
    Environ Toxicol; 2024 Jul; 39(7):3967-3979. PubMed ID: 38598732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MEHP on testosterone synthesis via Sirt1/Foxo1/Rab7 signaling pathway inhibition of lipophagy in TM3 cells.
    Hao Y; Tian X; Yan F; Wang X; Huang J; Li L
    Ecotoxicol Environ Saf; 2024 Jun; 277():116394. PubMed ID: 38663197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phthalate Exposure and Coronary Heart Disease: Possible Implications of Oxidative Stress and Altered miRNA Expression.
    Moawad AM; Awady S; Ali AAER; Abdelgwad M; Belal S; Taha SHN; Mohamed MI; Hassan FM
    Chem Res Toxicol; 2024 May; 37(5):723-730. PubMed ID: 38636967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mono-2-ethylhexyl phthalate (MEHP) alters histiotrophic nutrition pathways and epigenetic processes in the developing conceptus.
    Sant KE; Dolinoy DC; Jilek JL; Shay BJ; Harris C
    J Nutr Biochem; 2016 Jan; 27():211-8. PubMed ID: 26507544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure to the phthalate metabolite MEHP impacts survival and growth of human ovarian follicles in vitro.
    Panagiotou EM; Damdimopoulos A; Li T; Moussaud-Lamodière E; Pedersen M; Lebre F; Pettersson K; Arnelo C; Papaikonomou K; Alfaro-Moreno E; Lindskog C; Svingen T; Damdimopoulou P
    Toxicology; 2024 Jun; 505():153815. PubMed ID: 38685446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Disruption of Glucose and Lipid Metabolism Induced by Phthalates in Human Hepatocytes and White Adipocytes.
    Tian Y; Xu M; Shang H; You L; Yang J; Jia X; Yang H; Wu Y; Yang X; Wan Y
    Toxics; 2024 Mar; 12(3):. PubMed ID: 38535947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicoproteomics of Mono(2-ethylhexyl) phthalate and Perfluorooctanesulfonic Acid in Models of Prostatic Diseases.
    Thomas S; Ricke WA; Li L
    Chem Res Toxicol; 2023 Feb; 36(2):251-259. PubMed ID: 36749316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of di (2-ethylhexyl) phthalate and high-fat diet on lipid metabolism in rats by JAK2/STAT5.
    Zhang Y; Zhou L; Zhang Z; Xu Q; Han X; Zhao Y; Song X; Zhao T; Ye L
    Environ Sci Pollut Res Int; 2020 Feb; 27(4):3837-3848. PubMed ID: 31732953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Notch pathway on lipid accumulation induced by mono-2-ethylhexyl phthalate on 3T3-L1 cells.
    Qi W; Xu Q; Xu Y; Wang Z; Yang L; Guo S; Shi Y; Zhao T; Zhou L; Ye L
    Ecotoxicol Environ Saf; 2021 Jan; 208():111472. PubMed ID: 33091777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between endocrine disrupting chemicals and MAFLD: Evidence from NHANES survey.
    Lei R; Xue B; Tian X; Liu C; Li Y; Zheng J; Luo B
    Ecotoxicol Environ Saf; 2023 May; 256():114836. PubMed ID: 37001192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heavy Metals, Halogenated Hydrocarbons, Phthalates, Glyphosate, Cordycepin, Alcohol, Drugs, and Herbs, Assessed for Liver Injury and Mechanistic Steps.
    Teschke R; Xuan TD
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):314. PubMed ID: 36472117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aluminum, Arsenic, Beryllium, Cadmium, Chromium, Cobalt, Copper, Iron, Lead, Mercury, Molybdenum, Nickel, Platinum, Thallium, Titanium, Vanadium, and Zinc: Molecular Aspects in Experimental Liver Injury.
    Teschke R
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of endocrine disrupting chemicals on the expression of RACK1 and LPS-induced THP-1 cell activation.
    Masi M; Maddalon A; Iulini M; Linciano P; Galbiati V; Marinovich M; Racchi M; Corsini E; Buoso E
    Toxicology; 2022 Oct; 480():153321. PubMed ID: 36113621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of the Association between Thiols and Oxidative Stress Markers in Children with Obesity.
    D'Alessandro A; Di Felice G; Manco M; Pastore A; Pezzi S; Mariani M; Fintini D; Onetti Muda A; Porzio O
    Nutrients; 2022 Sep; 14(17):. PubMed ID: 36079892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population.
    Lee H; Lim TS; Kim SU; Kim HC
    Hepatol Int; 2022 Dec; 16(6):1308-1317. PubMed ID: 36070124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary inflammatory index and osteoporosis: the National Health and Nutrition Examination Survey, 2017-2018.
    Zhao S; Gao W; Li J; Sun M; Fang J; Tong L; He Y; Wang Y; Zhang Y; Xu Y; Yang S; Jin L
    Endocrine; 2022 Dec; 78(3):587-596. PubMed ID: 36044108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic dysfunction-associated fatty liver disease and chronic hepatitis B.
    Huang SC; Kao JH
    J Formos Med Assoc; 2022 Nov; 121(11):2148-2151. PubMed ID: 35981929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic consequences of a mixture of endocrine-disrupting chemicals in male mice.
    Rahman MS; Pang WK; Amjad S; Ryu DY; Adegoke EO; Park YJ; Pang MG
    J Hazard Mater; 2022 Aug; 436():129236. PubMed ID: 35739755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals.
    Chan KE; Koh TJL; Tang ASP; Quek J; Yong JN; Tay P; Tan DJH; Lim WH; Lin SY; Huang D; Chan M; Khoo CM; Chew NWS; Kaewdech A; Chamroonkul N; Dan YY; Noureddin M; Muthiah M; Eslam M; Ng CH
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2691-2700. PubMed ID: 35587339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.